Stryker's $400M Funding In CMR Surgical 'Gives It Another Potential Growth Vertical,' Analysts Say

◆ ◆ The Wire takeaway

You can now position your soft-tissue robotics startup as an out-of-the-box solution for outpatient centres competing against Stryker’s expanding one-stop shop. This deal signals increasing integration of implants and robotics under major players, raising the bar on partnerships and exclusivity in US medtech sales.